Cholangiocarcinoma: all 930 studies
Page 6 of 10. Open to participants first (292), then studies with results posted, then the rest; newest registration first within each.
- FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)TerminatedNCT05432193Phase 1
- CH-EUS in Diagnosis of Inoperable Bile Duct TumorsStatus unknownNCT05418543Not applicable
- Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer PatientsCompletedNCT05411133Phase 1
- Minimally Invasive Versus Open Surgery for PHCCompletedNCT05402618
- HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic CholangiocarcinomaStatus unknownNCT05400902Phase 2
- AI Guidance for Biopsy in Suspected CholangiocarcinomaActive, not recruitingNCT05374122Not applicable
- HAIC Combined With Donafenib and Sintilimab for Unresectable ICCCompletedNCT05348811Phase 2
- A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid TumorsTerminatedNCT05346484Phase 1
- Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic CholangiocarcinomaStatus unknownNCT05327907
- A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionTerminatedNCT05325866Phase 1/2
- Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid TumorsActive, not recruitingNCT05311618Phase 1
- Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsCompletedNCT05292859
- Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver CancerWithdrawnNCT05292443
- HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic CholangiocarcinomaStatus unknownNCT05290116Phase 2
- Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal CancerActive, not recruitingNCT05277766Phase 1
- Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsTerminatedNCT05275478Phase 1/2
- Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.CompletedNCT05266300
- To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsCompletedNCT05253053Phase 1/2
- Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic CholangiocarcinomaStatus unknownNCT05251662Phase 2
- TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic CholangiocarcinomaStatus unknownNCT05247996Not applicable
- A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene AlterationsTerminatedNCT05242822Phase 1
- Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic MalignanciesStatus unknownNCT05240690Phase 1
- Treat Primary and Metastatic Liver TumorsWithdrawnNCT05240040
- Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract CancerCompletedNCT05239169Phase 2
- A Clinical Study of DEB-TACE Combined With Surufatinib and Camrelizumab in the Treatment of Inoperable or Metastatic ICCCompletedNCT05236699Phase 2
- Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver TumorsTerminatedNCT05220722Phase 1/2
- Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsActive, not recruitingNCT05215574Phase 1
- Percutaneous Cholangiopancreatoscopy RegistryActive, not recruitingNCT05210322
- PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.Status unknownNCT05207735Phase 2
- A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsTerminatedNCT05194072Phase 1
- Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/RearrangementsActive, not recruitingNCT05174650Phase 2
- HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsTerminatedNCT05124743
- Endoscopic Versus Radiologic Biliary Drainage for Perihilar Malignant ObstructionStatus unknownNCT05078801
- RFA Combined With Chemotherapy for Unresectable CholangiocarcinomaCompletedNCT05028439Not applicable
- GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTCWithdrawnNCT05019677Phase 2
- Cryoablation Combined with Sintilimab Plus Lenvatinib in Patients with Advanced Intrahepatic CholangiocarcinomaCompletedNCT05010668Phase 2
- Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract CancerTerminatedNCT05009953Phase 2
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic CholangiocarcinomaStatus unknownNCT04961788Phase 2
- Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver TumorsStatus unknownNCT04951141Early Phase 1
- Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry.CompletedNCT04937322
- Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in CholangiocarcinomaCompletedNCT04919642Phase 2
- Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesActive, not recruitingNCT04913337Phase 1/2
- Maintenance Niraparib and Dostarlimab in Advanced CholangiocarcinomaWithdrawnNCT04895046Phase 2
- Biomarker Discovery in Patients With Advanced Biliary Tract CancerCompletedNCT04871321
- A Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant TumorsTerminatedNCT04866836Phase 2
- Photodynamic Therapy for CholangiocarcinomaCompletedNCT04860154Not applicable
- A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical ResectionStatus unknownNCT04856761
- Liver Transplantation in Patients With Incidental Hepatocellular-cholangiocarcinoma and Intrahepatic Cholangiocarcinoma: A Single-center ExperienceStatus unknownNCT04848805
- Prognosis of Nutritional Status for Surgical Peri Hilar CholangiocarcinomaStatus unknownNCT04846192
- DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic CholangiocarcinomaCompletedNCT04834674Phase 2
- Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsActive, not recruitingNCT04802876Phase 2
- REMS Combined With TAI for Unresectable HCCompletedNCT04801160Not applicable
- Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative RecurrenceStatus unknownNCT04782804Phase 1/2
- I-125 Seeds Loaded Stent Insertion for Inoperable Hilar CholangiocarcinomaStatus unknownNCT04779788Not applicable
- Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid TumorsStatus unknownNCT04764084Phase 1
- Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsCompletedNCT04742959Phase 1/2
- Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract CancerTerminatedNCT04727541Phase 2
- Pilot Study on the Evaluation of Irreversible Electroporation Technique in Infiltrating Perihilar CholangiocarcinomaWithdrawnNCT04717687Not applicable
- Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic CholangiocarcinomaActive, not recruitingNCT04708067Phase 1
- Infusion System for Hepatic CancerActive, not recruitingNCT04684862Not applicable
- Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard TherapyCompletedNCT04676633Phase 1
- Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence FactorsActive, not recruitingNCT04669496Phase 2/3
- A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or CholangiocarcinomaStatus unknownNCT04668976Phase 2
- Lenvatinib in Patients With Previously Treated Advanced Biliary Tract CancerCompletedNCT04656249Phase 2
- A Study of BMS-936558 With SBRT After Induction Chemotherapy in CholangiocarcinomaTerminatedNCT04648319Phase 2
- Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract CancerCompletedNCT04642664Phase 2
- Observational Study on Patients With Hepatobiliary TumorsStatus unknownNCT04637048
- PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard TreatmentActive, not recruitingNCT04634058Phase 2
- ENHANCED RECOVERY AFTER BILIARY TRACT SURGERYStatus unknownNCT04633382Not applicable
- Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar CholangiocarcinomaCompletedNCT04611100Not applicable
- Recurrence After Whipple's (RAW) StudyCompletedNCT04596865
- Implementing Acupuncture and Chinese Herbal Medicine Into Palliative CareWithdrawnNCT04584775Not applicable
- DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct StrictureCompletedNCT04568512Not applicable
- A Study of ICP-192 in Patients With Advanced Solid TumorsStatus unknownNCT04565275Phase 1/2
- Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract CancerTerminatedNCT04561453
- A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in KoreaWithdrawnNCT04546828Phase 2
- Cisplatin and Gemcitabine Chemotherapy and Lenvatinib for Patients With Unresectable Intrahepatic CholangiocarcinomaStatus unknownNCT04527679Phase 2
- REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid TumorsCompletedNCT04526106Phase 1/2
- Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node MetastasisStatus unknownNCT04523402Phase 2
- Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsActive, not recruitingNCT04521686Phase 1
- Hepatic Artery Infusion (HAI) Program at Duke UniversityWithdrawnNCT04511793Not applicable
- Liver Cancer Registry PlatformActive, not recruitingNCT04510740
- Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene RearrangementsApproved for marketingNCT04507503
- PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence FactorsStatus unknownNCT04506281Phase 2
- PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)CompletedNCT04484636Not applicable
- Neoadjuvant Therapy in Biliary AdenocarcinomaWithdrawnNCT04480190Phase 1
- A Trial of Famitinib in Patients With Failure of First-Line Treatment For Intrahepatic CholangiocarcinomaWithdrawnNCT04479904Phase 2
- Nutrition in Gastrointestinal TumorsCompletedNCT04476082
- Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various CancersActive, not recruitingNCT04459273Phase 1
- A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced MalignanciesCompletedNCT04440943Phase 1
- Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SCompletedNCT04430842Phase 1
- the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma PatientsStatus unknownNCT04415190
- Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic CholangiocarcinomaStatus unknownNCT04413734Phase 2
- Irreversible Electroporation of Unresectable Liver TumorsWithdrawnNCT04404647Not applicable
- Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary TumorsCompletedNCT04400357Not applicable
- Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular CarcinomaStatus unknownNCT04386772Not applicable
- Advanced Endoscopy During COVID-19CompletedNCT04385147
- Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic CholangiocarcinomaCompletedNCT04361331Phase 2
- Two-in-one Covered and Uncovered Metal StentStatus unknownNCT04337333Not applicable